Hunan Debang Pharmaceutical Co., Ltd. was established in August 2004 with a registered capital of 30 million yuan. It deals in more than 5,000 varieties of products, mainly including Chinese medicinal materials, Chinese patent medicines, traditional Chinese medicine decoction pieces, chemical pharmaceutical preparations, antibiotic preparations, biochemical drugs, biological products, medical devices, health food, etc. It is a medium-sized pharmaceutical wholesale enterprise that has passed GSP certification.
The company has always adhered to the business tenet of "quality as life, customers as the core"; it implements the market competition strategy of "winning by quality, winning by price, winning by service, winning by scale". It now has more than 1,000 terminal customers and annual sales revenue of more than 500 million yuan. We look forward to more friends who are interested in the pharmaceutical marketing cause and brave enough to challenge themselves to join us. We are also confident in providing you with an excellent platform to realize your life ideals!
Now, due to the company's development and growth, it will move to No. 518 Tongzipo West Road. The new site covers an area of 100 mu, of which the warehouse area reaches 70,000 square meters. It integrates office buildings, employee dormitory buildings, employee canteens, business buildings, basketball courts, etc., with first-class office space and a modern working and living environment. We look forward to your joining!
Contact person: *** Ms. Yin
Contact phone: 88701207 (office)
Email: 24830312@*
Company new address: No. 518 Tongzipo West Road, Hexi, Changsha City (next to Wasion Electronics Group). You can take Bus No. 118 and get off at Baoli Lugu Linyu West, then walk straight west for 500 meters.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows